Iconiq Capital’s Edwards Lifesciences EW Stock Holding History

Iconiq Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,938	Closed	-$230K	–	202
2025 Q2	$230K	Buy	+2,938	New	+$219K	﹤0.01%	363

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Iconiq Capital's EW Position: Q3 2025 in Review

Iconiq Capital sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 2,938 shares — an estimated $230K sold.

Iconiq Capital first reported a position in EW in Q2 2025 and held it in 1 quarter. The position peaked at $230K in Q2 2025. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Iconiq Capital reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Iconiq Capital sold 2,938 Edwards Lifesciences shares in Q3 2025, an estimated $230K.
Iconiq Capital first reported a position in Edwards Lifesciences in Q2 2025 and held it in 1 quarter.
Iconiq Capital's Edwards Lifesciences position peaked at $230K in Q2 2025.
1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Iconiq Capital's 13F filing for Q3 2025, filed 14 Nov 2025.